Health Law & Business News

Mexico Weighs U.S. Plan to Strip Biologic Drugs From Trade Pact

Dec. 3, 2019, 8:45 PM

Mexico is considering a U.S. proposal to remove protections for biologic drugs from a renegotiated Nafta trade deal, a plan that could help clear a hurdle to an agreement and deal a blow to brand-name pharmaceutical companies.

The proposed change would drop language in the U.S.-Mexico-Canada Agreement offering 10 years of market protection for drug makers from cheaper generic spinoffs, according to half a dozen sources familiar with the talks who asked not to be named because the negotiations are private. The move would leave it up to the individual countries to set their own laws on biologics, which are...

To read the full article log in. To learn more about a subscription click here.